Research & References

UKPDS (UK Prospective Diabetes Study)

Lancet, 1998. Intensive blood glucose control reduces microvascular complications by ~35% per 1% HbA1c reduction. Foundation of current HbA1c management targets.

DiRECT Trial (Diabetes Remission Clinical Trial)

Lean et al., Lancet, 2018. 46% of participants achieved remission of type 2 diabetes at 1 year through intensive dietary weight loss intervention.

ADA Standards of Medical Care in Diabetes — 2024

American Diabetes Association. Annual clinical practice guidelines including diagnostic criteria, HbA1c targets, and treatment algorithms.

Berberine meta-analysis (Dong et al.)

Journal of Ethnopharmacology, 2012. Meta-analysis of 14 RCTs showing berberine reduces fasting blood glucose by ~20 mg/dL and HbA1c by ~0.7% in type 2 diabetics.

Alpha-Lipoic Acid in Diabetic Neuropathy (SYDNEY 2 Trial)

Ziegler et al., Diabetes Care, 2006. ALA 600 mg/day significantly reduced neuropathy symptom scores (TOSS) vs. placebo in a multicenter RCT.

Benfotiamine and Neuropathy

Haupt et al., Int J Clin Pharmacol Ther, 2005. Benfotiamine reduces advanced glycation end products in peripheral nerves, improving symptom scores.

Metformin and Vitamin B12 Deficiency

de Jager et al., BMJ, 2010. Long-term metformin use associated with B12 deficiency, which can worsen peripheral neuropathy.

DASH-Sodium Trial

Sacks et al., NEJM, 2001. Reducing sodium from 3,300 to 1,500 mg/day lowered systolic BP by 8.9 mmHg in hypertensive participants on DASH diet.

Cochrane Review: Sodium Reduction and Blood Pressure

Aburto et al., Cochrane, 2020. Meta-analysis of 185 RCTs confirming consistent BP reduction with moderate sodium restriction.

AREDS2 (Age-Related Eye Disease Study 2)

NIH / National Eye Institute, 2013. Lutein 10mg + zeaxanthin 2mg combination reduced progression to advanced AMD by 25% vs. placebo.

Bilberry and Visual Acuity

Ozawa et al., J Nutr Health Aging, 2020. RCT (n=60) showing bilberry extract improves contrast sensitivity and reduces eye fatigue vs. placebo.

Diabetes and Dementia Risk

Biessels et al., Lancet Neurology, 2006. Systematic review showing type 2 diabetes associated with 2-fold increased risk of dementia.

Magnesium and Sleep (RCT)

Abbasi et al., J Res Med Sci, 2012. RCT (n=46, older adults) showing magnesium supplementation improves sleep efficiency, onset time, and melatonin levels.

Magnesium and Blood Sugar — Meta-analysis

Simental-Mendia et al., Magnesium Research, 2019. Meta-analysis of 18 RCTs showing magnesium reduces fasting glucose and HbA1c in type 2 diabetics.

CDC Diabetes Prevention Program (DPP)

Knowler et al., NEJM, 2002. Intensive lifestyle intervention reduced progression from prediabetes to diabetes by 58% over 3 years.

Collagen and Lean Mass Retention

Oertzen-Hagemann et al., Nutrients, 2019. Collagen peptide supplementation combined with resistance training significantly improved body composition vs. exercise alone.